Kiyohide Nunoi

3PUBLICATIONS
4CO-AUTHORS
Medical biochemistry - carbohydratesFood properties (incl. characteristics and health benefits)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 15, 2019
Basal insulin secretion capacity predicts the initial response and maximum levels of beta-hydroxybutyrate during therapy with the sodium-glucose co-transporter-2 inhibitor tofogliflozin, in relation to weight loss.

Yuichi Sato, Kiyohide Nunoi, Kohei Kaku

|Apr 05, 2019
Renal effects of a sodium-glucose cotransporter 2 inhibitor, tofogliflozin, in relation to sodium intake and glycaemic status.

Kiyohide Nunoi, Yuichi Sato, Kohei Kaku

|Mar 01, 2019
Effects of sodium-glucose cotransporter 2 inhibitor, tofogliflozin, on the indices of renal tubular function in patients with type 2 diabetes.

Kiyohide Nunoi, Yuichi Sato, Kohei Kaku

Pageof 1

Frequent Collaborators

3 joint publications

Kohei Kaku

3 joint publications

Hideki Suganami

1 joint publications

Yuichi Sato

1 joint publications

Akihiro Yoshida